Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "vaccines"

711 News Found

One more lab approved for batch-testing and release of Covid-19 vaccines
News | August 17, 2021

One more lab approved for batch-testing and release of Covid-19 vaccines

National Institute of Animal Biotechnology, Hyderabad can now conduct quality checks and consequent lot release of Covid-19 vaccines


Combinations of Sputnik V component with other vaccines demonstrate favourable results: RDIF
Drug Approval | August 05, 2021

Combinations of Sputnik V component with other vaccines demonstrate favourable results: RDIF

AstraZeneca, Sinopharm and Moderna were part of the study


Trials of three more vaccines are in advanced stage: Modi
News | June 08, 2021

Trials of three more vaccines are in advanced stage: Modi

The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age


Govt. to supply 1.92 crore COVID vaccines during May 16-31
News | May 16, 2021

Govt. to supply 1.92 crore COVID vaccines during May 16-31

A total quantum of more than 4.39 crore doses was also available for direct procurement by the states as well as private hospitals in the month of May 2021


Hester to commercialize vaccines for animals
News | April 09, 2021

Hester to commercialize vaccines for animals

Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection


Merck accelerates expansion plans for single-use products critical to manufacturing vaccines
News | March 18, 2021

Merck accelerates expansion plans for single-use products critical to manufacturing vaccines

The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.


Pfizer and Valneva report promising Phase 3 Lyme disease vaccine results
Clinical Trials | March 24, 2026

Pfizer and Valneva report promising Phase 3 Lyme disease vaccine results

The company plans to submit the vaccine for regulatory review


Touchlight & NEB launch game-changing benchtop DNA kit
News | March 20, 2026

Touchlight & NEB launch game-changing benchtop DNA kit

This linear, covalently closed, double-stranded DNA offers a rapid, cell-free alternative to traditional plasmid DNA, addressing a critical bottleneck in nucleic acid therapeutics development


SK bioscience bags fresh backing to accelerate fight against respiratory disease
News | March 20, 2026

SK bioscience bags fresh backing to accelerate fight against respiratory disease

RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute


GSK expands RSV vaccine to younger adults in US, targeting high-risk 18–49 age group
News | March 16, 2026

GSK expands RSV vaccine to younger adults in US, targeting high-risk 18–49 age group

Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk